Nanotechnology Fundamentals Applied to Clinical Infectious Diseases and Public Health

Overview

Journal Open Forum Infect Dis

Specialty Infectious Diseases

Date 2022 Jan 6

PMID 34988245

Citations 4

Authors

Ellis Tobin

Sara Brenner

Affiliations

Soon will be listed here.

Abstract

Nanotechnology involves the discovery and fabrication of nanoscale materials possessing unique physicochemical properties that are being employed in industry and medicine. Infectious Diseases clinicians and public health scientists utilize nanotechnology applications to diagnose, treat, and prevent infectious diseases. However, fundamental principles of nanotechnology are often presented in technical formats that presuppose an advanced knowledge of chemistry, physics, and engineering, thereby limiting the clinician's grasp of the underlying science. While nanoscience is technically complex, it need not be out of reach of the clinical practitioner. The aim of this review is to introduce fundamental principles of nanotechnology in an accessible format, describe examples of current clinical infectious diseases and public health applications, and provide a foundation that will aid understanding of and appreciation for this burgeoning and important field of science.

Citing Articles

Antibacterial activity of selenium nanoparticles/copper oxide (SeNPs/CuO) nanocomposite against some multi-drug resistant clinical pathogens.

Asaad A, Saied S, Torayah M, Abu-Elsaad N, Awad S BMC Microbiol. 2025; 25(1):33.

PMID: 39833699 PMC: 11745003. DOI: 10.1186/s12866-025-03743-9.

Nanomedicine and clinical diagnostics part I: applications in conventional imaging (MRI, X-ray/CT, and ultrasound).

Butt A, Bach H Nanomedicine (Lond). 2024; 20(2):167-182.

PMID: 39661327 PMC: 11731363. DOI: 10.1080/17435889.2024.2439776.

Nanotechnology in the Diagnosis and Treatment of Antibiotic-Resistant Infections.

Ioannou P, Baliou S, Samonis G Antibiotics (Basel). 2024; 13(2).

PMID: 38391507 PMC: 10886108. DOI: 10.3390/antibiotics13020121.

Metal-Organic Framework-Based Nanomedicines for the Treatment of Intracellular Bacterial Infections.

Qi X, Shen N, Al Othman A, Mezentsev A, Permyakova A, Yu Z Pharmaceutics. 2023; 15(5).

PMID: 37242762 PMC: 10220673. DOI: 10.3390/pharmaceutics15051521.

Biogenic Selenium Nanoparticles in Biomedical Sciences: Properties, Current Trends, Novel Opportunities and Emerging Challenges in Theranostic Nanomedicine.

Zambonino M, Quizhpe E, Mouheb L, Rahman A, Agathos S, Dahoumane S Nanomaterials (Basel). 2023; 13(3).

PMID: 36770385 PMC: 9921003. DOI: 10.3390/nano13030424.

References

Adler-Moore J, Lewis R, Bruggemann R, Rijnders B, Groll A, Walsh T . Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B. Clin Infect Dis. 2019; 68(Suppl 4):S244-S259. PMC: 6495008. DOI: 10.1093/cid/ciz064. View

Paladini F, Pollini M . Antimicrobial Silver Nanoparticles for Wound Healing Application: Progress and Future Trends. Materials (Basel). 2019; 12(16). PMC: 6719912. DOI: 10.3390/ma12162540. View

Bawa R . Patents and nanomedicine. Nanomedicine (Lond). 2007; 2(3):351-74. DOI: 10.2217/17435889.2.3.351. View

Haun J, Yoon T, Lee H, Weissleder R . Magnetic nanoparticle biosensors. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010; 2(3):291-304. DOI: 10.1002/wnan.84. View

Adler-Moore J, Proffitt R . AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience. J Antimicrob Chemother. 2002; 49 Suppl 1:21-30. DOI: 10.1093/jac/49.suppl_1.21. View

Kokkinos P, Mantzavinos D, Venieri D . Current Trends in the Application of Nanomaterials for the Removal of Emerging Micropollutants and Pathogens from Water. Molecules. 2020; 25(9). PMC: 7248945. DOI: 10.3390/molecules25092016. View

Barillo D, Marx D . Silver in medicine: a brief history BC 335 to present. Burns. 2014; 40 Suppl 1:S3-8. DOI: 10.1016/j.burns.2014.09.009. View

Rosi N, Mirkin C . Nanostructures in biodiagnostics. Chem Rev. 2005; 105(4):1547-62. DOI: 10.1021/cr030067f. View

Kalfon P, De Vaumas C, Samba D, Boulet E, Lefrant J, Eyraud D . Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients. Crit Care Med. 2007; 35(4):1032-9. DOI: 10.1097/01.CCM.0000259378.53166.1B. View

10.

Lopez-Berestein G . Liposomes as carriers of antimicrobial agents. Antimicrob Agents Chemother. 1987; 31(5):675-8. PMC: 174813. DOI: 10.1128/AAC.31.5.675. View

11.

Mylonakis E, Clancy C, Ostrosky-Zeichner L, Garey K, Alangaden G, Vazquez J . T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin Infect Dis. 2015; 60(6):892-9. DOI: 10.1093/cid/ciu959. View

12.

Omolo C, Kalhapure R, Agrawal N, Rambharose S, Mocktar C, Govender T . Formulation and Molecular Dynamics Simulations of a Fusidic Acid Nanosuspension for Simultaneously Enhancing Solubility and Antibacterial Activity. Mol Pharm. 2018; 15(8):3512-3526. DOI: 10.1021/acs.molpharmaceut.8b00505. View

13.

. Nanomedicine and the COVID-19 vaccines. Nat Nanotechnol. 2020; 15(12):963. PMC: 7692425. DOI: 10.1038/s41565-020-00820-0. View

14.

Johnston H, Hutchison G, Christensen F, Peters S, Hankin S, Stone V . A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol. 2010; 40(4):328-46. DOI: 10.3109/10408440903453074. View

15.

Kuhn D, Ghannoum M . Candida biofilms: antifungal resistance and emerging therapeutic options. Curr Opin Investig Drugs. 2004; 5(2):186-97. View

16.

Seymour C . Audit of catheter-associated UTI using silver alloy-coated Foley catheters. Br J Nurs. 2006; 15(11):598-603. DOI: 10.12968/bjon.2006.15.11.21227. View

17.

Tokel O, Inci F, Demirci U . Advances in plasmonic technologies for point of care applications. Chem Rev. 2014; 114(11):5728-52. PMC: 4086846. DOI: 10.1021/cr4000623. View

18.

Swindells S, Andrade-Villanueva J, Richmond G, Rizzardini G, Baumgarten A, Masia M . Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression. N Engl J Med. 2020; 382(12):1112-1123. DOI: 10.1056/NEJMoa1904398. View

19.

Nagar A, Pradeep T . Clean Water through Nanotechnology: Needs, Gaps, and Fulfillment. ACS Nano. 2020; 14(6):6420-6435. DOI: 10.1021/acsnano.9b01730. View

20.

Ratsimbasoa A, Randriamanantena A, Raherinjafy R, Rasoarilalao N, Menard D . Which malaria rapid test for Madagascar? Field and laboratory evaluation of three tests and expert microscopy of samples from suspected malaria patients in Madagascar. Am J Trop Med Hyg. 2007; 76(3):481-5. View